Exfoliation Syndrome
9
1
1
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
11.1%
1 terminated out of 9 trials
85.7%
-0.8% vs benchmark
33%
3 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (9)
Long-term Safety and Efficacy of a Modified Suprachoroidal Silicone Tube (SST) Shunt
A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma
Imaging Lens Deposits in Exfoliation Syndrome
24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed Combination
Early Diagnosis in Glaucoma With GDxVcc
Central Corneal Thickness in Glaucoma
Randomized Prospective Study of Selective Laser Trabeculoplasty (SLT) Versus Argon Trabeculoplasty (ALT) in Patients With Pseudoexfoliation Glaucoma and Ocular Hypertension
The International Collaborative Exfoliation Syndrome Treatment Study
Assessing Cosopt Switch Patients